Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+55224Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+57229Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+89482Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+92329Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+109160Peak area normalizedmale diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+112773Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+124613Peak area normalizedmale diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+135817Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+140259Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+142385Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+159565Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+183117Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+197365Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedfemale diabetic no neuropathy

Return to search page
  logo